ACTA & Public Safety: Counterfeit Agreement Peter Maybarduk Public Citizen October 28, 2010.

Slides:

Advertisements

Similar presentations

External Trade 1 5th Global Congress Combating Counterfeiting and Piracy Global and Regional IPR Enforcement Initiatives Luc-Pierre Devigne Head of Intellectual.

Advertisements

1 n European Commission 4th Global Congress: Combating Counterfeiting and Piracy Dubai – 3 February 2008 An Urgent Need to Better Respond to the Global.

Improving Legislative Frameworks and Enforcement Measures Against IP Crime Mr. Khoo Boon Hui Commissioner, Singapore Police Force Vice-President for Asia,

U.S. Government Coordinated Approach to IPR Protection and Enforcement 4 th Global Congress on Combating Counterfeiting & Piracy February 3-5, 2008 Wayne.

Preventing Infringement of Intellectual Property (IP) Rights in the Workplace Awareness raising to prevent infringement within [business name] September.

Preventing Infringement of Intellectual Property (IP) Rights in the Workplace Awareness raising to how to prevent infringement within [business name] September.

ISSUES AND CONCERNS IN THE UGANDA COUNTERFEIT GOODS BILL MULUMBA, MOSES.

Working world wide against HIV for the health and human rights of men who have sex with men Working world wide against HIV for the health and human rights.

Counterfeiting and Piracy: A Global Concern Heike Wollgast Senior Legal Officer World Intellectual Property Organization (WIPO) Building Respect for IP.

1 Brussels September 2008 by D G Shah Secretary General Indian Pharmaceutical Alliance Indian Pharmaceutical Industry Innovation, IPRs & Counterfeits.

The new offensive on enforcement of IPRs Domestic and international actions Domestic and international actions Pressures on developing countries Pressures.

The Monopoly Enforcement Agenda: A Global Overview Peter Maybarduk Essential Action 29 May 2009 Peter Maybarduk Essential Action 29 May 2009.

The Emergence of Anti-Counterfeiting Legislation in East Africa: Implications for Generic Supply and Treatment Access Mandeep Dhaliwal Tenu Avafia With.

WTO Dispute DS362 China vs. United States

Strengthening the Protection of Intellectual and Industrial Property Rights Deputy Manager Jan Hylleberg The Danish Association of the Pharmaceutical Industry.

The Global Access to Medicines Movement Peter Maybarduk April 15, 2011.

Office of the U.S. Trade Representative Kira M. Alvarez CHIEF NEGOTIATOR AND DEPUTY ASSISTANT U.S.T.R. For intellectual property enforcement.

5 TH ANNUAL NATIONAL CONFERENCE PUTTING THE CONSUMER FIRST 25 TH MARCH 2011 HELPLINE TRUST World Consumer Right’s Day.

Priorities to Combat Counterfeiting and Piracy Koji Yonetani Director Intellectual Property Affairs Division Ministry of Foreign Affairs of Japan

Complete ACTA negotiations and implement in 2010 Expand counterfeiting and piracy database Enhance transparency and monitoring Build respect for IPR’s.

John Anderson Chairman The Global Anti-Counterfeiting Group.

GMOs and the WTO Rules Mark Halle Minsk, 24 October 2008.

Intellectual Property in the Context of Growth and Development of the World Economy Luciano Daffarra, Attorney at Law Daffarra, d’Addio & Partners China-Italy.

IPR enforcement in the EU Evidence of impact of on the access to generics Johanna von Braun University of Cape Town, South Africa Kiev, 21/22 nd June 2010.

The emergence of an Enforcement Agenda Intellectual Property Rights and Access to Essential Medicines: Challenges and Opportunities in Free Trade Agreement.

© A. Kur Enforcing Intellectual Property Rights in Europe and in Third Countries - The Quest for Balance Prof. Annette Kur, MPI Munich.

Overview +Recap +Legal framework - points of interest +Next steps +Questions.

An Introduction to IPR Enforcement Tony Bonnici UNECE Skopje, 1 April 2009.

CAPACITY BUILDING TRAINING PROGRAMME ON INTELLECTUAL PROPERTY RIGHTS AND RELATED WTO ISSUES April 28-May 2, 2008 Session 3 Enforcement under the TRIPS.

1 Stop Stock-outs! Access to Medicines for All! anti-counterfeiting initiatives and other access barriers Christa Cepuch OSI AEM Initiative – CS Role and.

1 SECTION 337 INVESTIGATIONS Managing Intellectual Property IP In China April 30, 2013 New York, New York.

U.S. Government Coordinated Approach to Intellectual Property Enforcement Third Global Congress on Counterfeiting & Piracy January 30, 2007 Office of the.

© 2007 Cisco Systems, Inc. All rights reserved.Cisco Confidential 1 Intellectual Property in Canada Morgan N. Elliott Global Policy & Government Affairs.

1 n June 2005European Commission KTC Seminar Seoul – 2 June 2004 The fight against counterfeiting and piracy: The fight against counterfeiting and piracy:

“Commercialization and enforcement of intellectual property rights” - Skopje, April 2009 UNECE ‘Recommendation M’ on the Use of Market Surveillance.

Regional Dialogue on EPAs, IP and Sustainable Development for ECOWAS Countries Dialogue organised by ICTSD, ENDA Tiers Monde & QUNO Saly (Dakar), Senegal,

1 CACP: Update from Washington Miami, Florida September 21, 2010.

Enforcement under the TRIPS Agreement [Shortened version of presentation] Regional Conference – IP Enforcement Cairo, November 9, 2008 Ms. Louise van Greunen.

‘Linkage’ & other TRIPS+ provisions: a public health perspective Karin Timmermans World Health Organization Seminar “Data exclusivity and patent Bangkok.

Jonathan Band Jonathan Band PLLC ACTA: A Quick Overview 1.

Current trends in EPA negotiations in relation to IPRs Fleur Claessens.

The Directive on Enforcement and The Customs Regulation Warsaw May 2006 Martin Ekvad Community Plant Variety Office Head of Legal Affairs.

TRIPS-Plus Pressures: Trade Agreements, and New Trade Policy Prof. Brook K. Baker OSI Kiev – IPRs & A2M, Sept. 16, 2009.

FREE TRADE AGREEMENTS Prathibha Siva Lawyers Collective HIV/AIDS Unit, India East Africa Consultation, September 2010.

1 TAIEX workshop for Southern Mediterranean countries on fighting against piracy and counterfeiting Consumer protection and awareness The Italian Policy.

TRIPS-plus-plus Enforcement and Anti-Counterfeiting Agenda and Seizures of Medicines-in-Transit Prof. Brook K. Baker, Health GAP Northeastern U. School.

WTO and SDGs: Issues before the Nairobi Ministerial TPP, TRIPS and Access to Medicines November 2015 Reji K. Joseph Associate Professor Institute.

ABA Annual Meeting All Rights Reserved Brief Overview of the Intellectual Property System in China Elizabeth Chien-Hale

International Intellectual Property Prof. Manheim Spring, 2007 Patent Compulsory Licensing Copyright © 2007.

The Use of Trademarks on the internet: Addressing the issue of on-line counterfeiting within the EU. WIPO, Geneva, September 17, Jean Bergevin. Head.

© 2012 Cengage Learning. All Rights Reserved. Objective 2.05 Understand responsible actions for conducting business. SLIDE 1 Objective 2.00 Understand.

Overview of presentation

Contracts – the small print

The Disposal of the IP Infringing Goods

Intellectual Property and Access to Affordable Medicines: TRIPS Plus

Free Trade and Intellectual Property Rights: Implications for the Canadian Pharmaceutical Environment Joel Lexchin MD School of Health Policy & Management.

MGT601 SME MANAGEMENT.

Exception to rules on free trade

International IP Roundtable UNLV, 8 April Seizure of Goods in Transit

FTAA and Access to Medicines

Anti-Counterfeiting Trade Agreement

IP Protection under the WTO

Presentation by: Nicholas Jackson Nozim Ishankulov Roberto Gonzalez

Intellectual Property Rights in Global Markets

Enforcement of Intellectual Property Rights in the Community Benoît Lory European Commission, DG Internal Market and Services Enforcement of Intellectual.

Injunctions: Still the right remedy?

The International Legal Framework

Counterfeiting and Intellectual property theft in Medicines World Bank Symposium March 10, 2005 Washington DC Frederick Razzaghi Director of Technical.

Jean Bergevin European Commission GROW.F5 –

IPR Border Enforcement in the United States

Presentation transcript:

ACTA & Public Safety: Counterfeit Agreement Peter Maybarduk Public Citizen October 28, 2010

ACTA & Public Health Two major public health interests implicated:  Access Risks for access to medicines  Safety The parties cite protecting consumers from unsafe products as a primary benefit of ACTA But:  ACTA’s scope is too broad: inclusion of civil IP infringements threatens competition at no benefit to safety  And simultaneously too narrow: ACTA only reaches those fake products that also infringe a trademark  Wrong tool: ACTA creates opportunity costs for more effective and comprehensive safety measures, including regulatory efforts

Border measures EU seizures of generics Police measures, ahead of judicial process A2M movement successful in improving ACTA’s border measures ACTA measures initially akin to Europe’s controversial rule

ACTA’s border measures now Patents out of ACTA’s border measures “For the purpose of this Agreement” Parties “may” apply provisions to goods in transit Applied “in a manner that does not discriminate [unreasonably] between IP rights.” But it is very important to discriminate between the distinct and discrete IP rights Unfortunately ACTA’s border measures still do not generally exclude civil infringements

Counterfeit

Drug regulationIP enforcement WTOWHO WTO

“Counterfeits” confusion Private rights  misappropriation counterfeiting (WTO)  unauthorized copy piracy Patents infringement Public health Counterfeit medicine = deliberately mislabeled (WHO)

“Counterfeits” confusion Private rights  misappropriation counterfeiting (WTO)  unauthorized copy piracy Patents infringement Public health Counterfeit medicine = deliberately mislabeled (WHO) All “intellectual property rights.”

“Counterfeits” confusion Private rights  misappropriation counterfeiting (WTO)  unauthorized copy piracy Patents infringement Public health Counterfeit medicine = deliberately mislabeled (WHO) All “intellectual property rights.” Fallacy #1: Any infringement can be loosely considered a fraudulent & “counterfeit” good.

“Counterfeits” confusion Private rights  misappropriation counterfeiting (WTO)  unauthorized copy piracy Patents infringement Public health Counterfeit medicine = deliberately mislabeled (WHO) All “intellectual property rights.” Fallacy #1: Any infringement can be loosely considered a fraudulent & “counterfeit” good. Fallacy #2: Similar remedies can be applied in similar manners and degrees for infringement of the distinct rights.

“Counterfeits” confusion Private rights  misappropriation counterfeiting (WTO)  unauthorized copy piracy Patents infringement Public health Counterfeit medicine = deliberately mislabeled (WHO) Counterfeits endanger public health. All “intellectual property rights.” Fallacy #1: Any infringement can be loosely considered a fraudulent & “counterfeit” good. Fallacy #2: Similar remedies can be applied in similar manners and degrees for infringement of the distinct rights.

“Counterfeits” confusion   patents All “intellectual property rights.” Fallacy #1: Any infringement can be loosely considered a fraudulent & “counterfeit” good. Fallacy #2: Similar remedies can be applied in similar manners and degrees for infringement of the distinct rights. Medical counterfeits endanger public health & safety (true). Fallacy #3: Tougher enforcement of (all) IPRs is a necessary, (primary) and effective means to fight fraud & protect health & safety.

Drug regulationIP enforcement WTOWHO WTO

ACTA’s bad precedent Treating competition like criminality Overly broad and aggressive IP enforcement rules justified by claims to public safety Opportunity costs for better public safety measures

Trends Some titular anti-counterfeiting initiatives focus squarely and broadly on IP enforcement, not directly on public safety.  ACTA, EAC Some TRIPS+ enforcement measures advanced in part on public health & safety rationales.  EC Council Reg 1383/2003 (cue Prof Flynn), US interagency effort Some health framework anti-counterfeiting initiatives risk incorporating IP enforcement agenda  WHO IMPACT (joint venture with IFPMA) In each case, potential public health costs.

Drug regulationIP enforcement WTOWHO WTO

Drug regulationIP enforcement WTOWHO WTO